HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

IDM 2101

a 10-epitope T-lymphocyte vaccine

Also Known As:

IDM-2101; IDM2101

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Vaccines: 124365
    - Cancer Vaccines: 4052
      - IDM 2101: 1

Experts

1.	Barve, Minal: 1 article (09/2008)
2.	Bender, James: 1 article (09/2008)
3.	Cunningham, Casey: 1 article (09/2008)
4.	Ganesa, Prasanthi: 1 article (09/2008)
5.	Greco, F Anthony: 1 article (09/2008)
6.	Ishioka, Glenn: 1 article (09/2008)
7.	Khong, Hung: 1 article (09/2008)
8.	Maples, Phillip B: 1 article (09/2008)
9.	McCune, David: 1 article (09/2008)
10.	Mills, Bonnie: 1 article (09/2008)

Related Diseases

1.

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

09/20/2008 - "The clinical efficacy, safety, and multiepitope immunogenicity of IDM-2101 was evaluated in patients with stage IIIB or IV non-small-cell lung cancer (NSCLC). "
09/20/2008 - "Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer."

Related Drugs and Biologics

1.	Vaccines